Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Total Non-Current Liabilities (2016 - 2026)

United Therapeutics' Total Non-Current Liabilities history spans 17 years, with the latest figure at $560.6 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities fell 24.05% to $560.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $560.6 million, a 24.05% decrease, with the full-year FY2025 number at $560.6 million, down 24.05% from a year prior.
  • Total Non-Current Liabilities hit $560.6 million in Q4 2025 for United Therapeutics, up from $546.3 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for UTHR hit a ceiling of $1.2 billion in Q3 2023 and a floor of $527.1 million in Q2 2025.
  • Historically, Total Non-Current Liabilities has averaged $976.3 million across 5 years, with a median of $1.1 billion in 2021.
  • Biggest five-year swings in Total Non-Current Liabilities: grew 11.49% in 2023 and later plummeted 43.46% in 2025.
  • Tracing UTHR's Total Non-Current Liabilities over 5 years: stood at $1.1 billion in 2021, then increased by 3.42% to $1.1 billion in 2022, then decreased by 3.39% to $1.1 billion in 2023, then crashed by 33.17% to $738.1 million in 2024, then dropped by 24.05% to $560.6 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for UTHR at $560.6 million in Q4 2025, $546.3 million in Q3 2025, and $527.1 million in Q2 2025.